PF-04856883

BIOLOGICAL2 trials

Sponsors

Pfizer

Conditions

Diabetes MellitusDiabetes Mellitus, Type 2Endocrine System DiseasesGlucose Metabolism DisordersHealthyMetabolic Diseases

Phase 1

Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females

CompletedNCT01301456

PfizerDiabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases +2

Start: 2011-03-31End: 2012-04-30Updated: 2018-02-09

A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers

CompletedNCT01637285

Start: 2012-08-31End: 2013-01-31Updated: 2015-07-31